-
Mashup Score: 0Emerging Opportunities to Reduce Racial, Ethnic, and Gender Disparities in Advanced Heart Failure Care∗ : - 7 month(s) ago
Corresponding Author
Source: www.jacc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 7Assessment of Autophagy Markers Suggests Increased Activity Following LVAD Therapy: - 7 month(s) ago
Highlights • Paired left ventricle samples from 16 patients pre- and post-LVAD display improvements in pathological gene expression signatures post-LVAD. • Gene and protein expression of key autoph…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Assessment of LV samples pre- & post-#LVAD therapy reveals that increased autophagy may underlie reverse remodeling seen w/ mechanical unloading. Read the new study by @Dr_TommyMartin, @mjuarros99, et al: https://t.co/GaAG4yLn8x #JACCBTS #HeartFailure #CardioTwitter @CUBoulder https://t.co/QXZqoeD766
-
-
Mashup Score: 3Racial and Ethnic Disparities in Ambulatory Heart Failure Ventricular Assist Device Implantation and Survival: - 7 month(s) ago
Abstract Background Durable left ventricular assist devices (VADs) improve survival in eligible patients, but allocation has been associated with patient race in addition to presumed heart failure …
Source: www.jacc.orgCategories: Cardiologists, Latest HeadlinesTweet-
Is there underutilization of #LVAD in ambulatory Black and Hispanic patients? #JACCHF article by @DebraDixonMD and @KBreathettMD https://t.co/uasS2vrkLU https://t.co/F2akGT3b2j
-
-
Mashup Score: 65JACC Scientific Statement Explores Impact of dLVAD on Quality of Life For HF Patients - American College of Cardiology - 7 month(s) ago
The use of durable mechanical circulatory support, such as a durable left ventricular assist device (dLVAD), is an important but often underutilized treatment for patients with advanced heart failure (HF), according to a JACC Scientific Statement published Sept. 25 in JACC. Ryan J. Tedford, MD, FACC, et al., write that, with innovations in dLVAD technology, the risk of several adverse events has been reduced, such as pump thrombosis, stroke and bleeding. The “average patient survival is now similar to
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The use of durable mechanical circulatory support, such as a durable #LVAD, is an important but often underutilized treatment for patients w/ advanced #heartfailure, according to a JACC Scientific Statement. Read more in #JACC: https://t.co/NJd2LTAuCp @JACCJournals https://t.co/OgPd5skGxX
-
-
Mashup Score: 3Durable Mechanical Circulatory Support: JACC Scientific Statement - 7 month(s) ago
Abstract Despite advances in medical therapy for patients with stage C heart failure (HF), survival for patients with advanced HF is <20% at 5 years. Durable left ventricular assist device (dLVAD) ...
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
New #JACC Scientific Statement! Contemporary durable mechanical circulatory support improves survival, #QoL and functional capacity but is underutilized in the treatment of advanced #heartfailure. Read more from this crucial work: https://t.co/7TmhJKYsKU #CardioTwitter #LVAD https://t.co/3GVGlrbKZp
-
-
Mashup Score: 0
After suffering a massive heart attack, Reverend Dr. Malik Shabazz, known for supporting essential causes, now has to focus on the most important one of all, which is his own health.
Source: www.clickondetroit.comCategories: General Medicine News, Latest HeadlinesTweet-
After 45 minutes of CPR & a 1% chance of survival, Reverend Dr. Malik Shabazz made a miraculous recovery from a massive #HeartAttack. Cardiac surgeon Dr. Kyle Miletic implanted a battery-operated device, called an #LVAD, to do all the work for his heart: https://t.co/PbGtWUl2XB
-
-
Mashup Score: 6CASTLE-HTx: Does AFib Ablation Improve Outcomes in Patients With End-State HF? - American College of Cardiology - 8 month(s) ago
Atrial fibrillation (AFib) ablation was associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage heart failure (HF), according to results from the CASTLE-HTx trial presented at ESC Congress 2023. Researchers randomly assigned 194 patients (median age 64 years; 19% women) with symptomatic AFib and end-stage HF and who were eligible for heart transplantation to either first-time catheter
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#AFib ablation associated with lower rates of deaths, urgent heart transplantation or #LVAD implantation compared w/ medical therapy in patients w/ end-stage #HeartFailure, based on CASTLE-HTx results. 📰 Read more: https://t.co/LMkFuAaj6C #ESCCongress #ACCHFT https://t.co/5Me35Rxs1N
-
-
Mashup Score: 3J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device - 8 month(s) ago
Author links open overlay panel Santiago Garcia MD, Robert Dowling MD, Eugene Chung MD, Gregory F. Egnaczyk MD, Terri L. Stewart-Dehner MD, Geoffrey A. Answini MD, Debra Paige RN, Dean J. Kereiakes
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @MyJSCAI: 📖FIH use of J-Valve to treat severe AR w #LVAD. #aorticregurgitation 💡🩺 ➡️https://t.co/3H2NbuzIH7 @djkereiakes @GAnswini @…
-
-
Mashup Score: 1Long-Term Mortality Risk in LVAD Largely Influenced by Clinical Events: 5-Year Data - 8 month(s) ago
Long-term 5-year mortality conditional on successful discharge after implantation with a fully magnetically levitated HeartMate 3 (HM3) left ventricular assist device (LVAD) is largely influenced by c
Source: www.crtonline.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A new #JACC study reported that long-term mortality risk in #LVAD is influenced by clinical events. Learn more about the results of the MOMENTUM 3 trial: https://t.co/F4cfAGWodP @CRT_meeting
-
-
Mashup Score: 2J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device - 9 month(s) ago
Author links open overlay panel Santiago Garcia MD, Robert Dowling MD, Eugene Chung MD, Gregory F. Egnaczyk MD, Terri L. Stewart-Dehner MD, Geoffrey A. Answini MD, Debra Paige RN, Dean J. Kereiakes
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @MyJSCAI: 📖FIH use of J-Valve to treat severe AR w #LVAD. #aorticregurgitation 💡🩺 ➡️https://t.co/3H2NbuzIH7 @djkereiakes @GAnswini @…
-
@bhtrachtenberg @DebraDixonMD @KBreathettMD @BiykemB @EiranGorodeski @MHBeasleyMD @MelvinEchols9 @Nikhil15 @JTThibs @md_viviana Great editorial by @TomCascinoMD highlighting #disparities #LVAD 👉 https://t.co/OTTwC7Yo8o https://t.co/hwSa7UoYp5